UK Pharma moves on transparency of financial relationships with health professionals
The UK’s pharmaceutical industry today announced another step towards greater transparency by revealing payments made to health care professionals in 2013 as an aggregate figure.
This is an interim step towards declaration of payments to individually named health care professionals, which will come into effect in 2016, said the Association of the British Pharmaceutical Industry (ABPI).
Transparency of financial relationships between industry and healthcare professionals is an important priority for the ABPI and its members. Last fall, ABPI member companies agreed to amend the ABPI Code of Practice to include disclosure requirements for payments made to individually named health care professionals in certain categories, including fees for consultancy services and sponsorship to attend third party medical education meetings. This will begin in 2016 for payments made in 2015.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze